Ottica Mantovani
⚠️ Moderate Risk
FEI: 3003695209 • Venice, Venice • ITALY
FEI Number
3003695209
Location
Venice, Venice
Country
ITALYAddress
Molo San Marco 4860, , Venice, Venice, Italy
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NOT IMPACT
The article appears to not have impact-resistant lenses in accordance with 21 CFR 801.410.
Refusal History
Frequently Asked Questions
What is Ottica Mantovani's FDA import refusal history?
Ottica Mantovani (FEI: 3003695209) has 1 FDA import refusal record(s) in our database, spanning from 7/5/2002 to 7/5/2002.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Ottica Mantovani's FEI number is 3003695209.
What types of violations has Ottica Mantovani received?
Ottica Mantovani has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Ottica Mantovani come from?
All FDA import refusal data for Ottica Mantovani is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.